Oppenheimer & CO Inc Regeneron Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 9,745 shares of REGN stock, worth $6.98 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,745
Previous 10,339 5.75%
Holding current value
$6.98 Million
Previous $10.9 Million 5.72%
% of portfolio
0.16%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$1024.09 - $1201.76 $608,309 - $713,845
-594 Reduced 5.75%
9,745 $10.2 Million
Q2 2024

Aug 07, 2024
BUY
$883.2 - $1071.19 $70,656 - $85,695
80 Added 0.78%
10,339 $10.9 Million
Q1 2024

May 06, 2024
SELL
$902.69 - $993.35 $1.69 Million - $1.86 Million
-1,869 Reduced 15.41%
10,259 $9.87 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $882,930 - $1 Million
1,139 Added 10.36%
12,128 $10.7 Million
Q3 2023

Nov 07, 2023
SELL
$692.45 - $844.37 $641,208 - $781,886
-926 Reduced 7.77%
10,989 $9.04 Million
Q2 2023

Aug 02, 2023
SELL
$700.03 - $830.35 $227,509 - $269,863
-325 Reduced 2.66%
11,915 $8.56 Million
Q1 2023

May 10, 2023
SELL
$680.49 - $826.97 $178,288 - $216,666
-262 Reduced 2.1%
12,240 $10.1 Million
Q4 2022

Feb 07, 2023
SELL
$705.89 - $766.39 $302,826 - $328,781
-429 Reduced 3.32%
12,502 $9.02 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $209,499 - $264,376
-365 Reduced 2.75%
12,931 $8.91 Million
Q2 2022

Aug 08, 2022
SELL
$548.35 - $738.84 $995,803 - $1.34 Million
-1,816 Reduced 12.02%
13,296 $7.86 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $1.21 Million - $1.42 Million
-2,034 Reduced 11.86%
15,112 $10.6 Million
Q4 2021

Feb 02, 2022
SELL
$543.48 - $670.97 $472,827 - $583,743
-870 Reduced 4.83%
17,146 $10.8 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $1.27 Million - $1.5 Million
2,209 Added 13.97%
18,016 $10.9 Million
Q2 2021

Aug 03, 2021
BUY
$472.8 - $558.54 $1.61 Million - $1.9 Million
3,404 Added 27.44%
15,807 $8.83 Million
Q1 2021

May 10, 2021
BUY
$446.73 - $548.2 $574,941 - $705,533
1,287 Added 11.58%
12,403 $5.87 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $333,853 - $424,370
698 Added 6.7%
11,116 $5.37 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $1.34 Million - $1.62 Million
2,456 Added 30.85%
10,418 $5.83 Million
Q2 2020

Aug 11, 2020
SELL
$493.32 - $643.92 $1.09 Million - $1.43 Million
-2,218 Reduced 21.79%
7,962 $4.97 Million
Q1 2020

May 08, 2020
BUY
$336.18 - $494.43 $147,583 - $217,054
439 Added 4.51%
10,180 $4.97 Million
Q4 2019

Feb 07, 2020
BUY
$274.13 - $376.51 $687,518 - $944,287
2,508 Added 34.67%
9,741 $3.66 Million
Q3 2019

Oct 31, 2019
SELL
$273.46 - $318.39 $216,033 - $251,528
-790 Reduced 9.85%
7,233 $2.01 Million
Q2 2019

Aug 09, 2019
BUY
$299.6 - $414.82 $363,115 - $502,761
1,212 Added 17.79%
8,023 $2.51 Million
Q1 2019

Apr 24, 2019
SELL
$372.08 - $439.57 $538,771 - $636,497
-1,448 Reduced 17.53%
6,811 $2.8 Million
Q4 2018

Jan 29, 2019
BUY
$335.82 - $403.04 $36,604 - $43,931
109 Added 1.34%
8,259 $3.09 Million
Q3 2018

Oct 26, 2018
SELL
$351.14 - $408.51 $35,114 - $40,851
-100 Reduced 1.21%
8,150 $3.29 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $565,784 - $685,840
1,988 Added 31.75%
8,250 $2.85 Million
Q1 2018

May 01, 2018
BUY
$315.82 - $393.78 $77,375 - $96,476
245 Added 4.07%
6,262 $2.16 Million
Q4 2017

Feb 07, 2018
SELL
$358.63 - $469.95 $623,298 - $816,773
-1,738 Reduced 22.41%
6,017 $2.26 Million
Q3 2017

Nov 09, 2017
BUY
$431.38 - $504.0 $3.35 Million - $3.91 Million
7,755
7,755 $3.47 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email